Chimera Investment (NYSE:CIM – Get Rating) released its earnings results on Thursday. The real estate investment trust reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.06), Briefing.com reports. Chimera Investment had a positive return on equity of 12.47% and a negative net margin of 8.93%. The firm had revenue of $116.89 million for the quarter, compared to analysts’ expectations of $131.19 million. During the same quarter in the previous year, the company posted $0.54 earnings per share. The firm’s quarterly revenue was down 32.1% on a year-over-year basis.
Chimera Investment Price Performance
CIM traded up $0.04 during midday trading on Friday, reaching $9.30. 1,687,774 shares of the company’s stock were exchanged, compared to its average volume of 1,979,739. The company has a debt-to-equity ratio of 3.45, a current ratio of 6.05 and a quick ratio of 6.05. Chimera Investment has a 1-year low of $7.72 and a 1-year high of $16.85. The stock has a market capitalization of $2.20 billion, a PE ratio of -14.31 and a beta of 1.05. The business’s 50-day moving average price is $9.30 and its 200 day moving average price is $10.92.
Wall Street Analyst Weigh In
CIM has been the subject of a number of analyst reports. Barclays lowered their target price on shares of Chimera Investment from $11.00 to $9.00 and set an “underweight” rating for the company in a research note on Monday, July 18th. Credit Suisse Group cut their price objective on shares of Chimera Investment to $9.50 in a report on Friday, July 22nd.
Institutional Trading of Chimera Investment
About Chimera Investment
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency and non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of residential, commercial mortgage loans, and other real estate related securities.
Featured Stories
- Get a free copy of the StockNews.com research report on Chimera Investment (CIM)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.